283 related articles for article (PubMed ID: 24847167)
1. Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Alvarez R; Larrosa D; Ramón C; Pascual J
Cephalalgia; 2015 Apr; 35(4):310-6. PubMed ID: 24847167
[TBL] [Abstract][Full Text] [Related]
2. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
3. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
[TBL] [Abstract][Full Text] [Related]
4. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
5. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients.
Riesco N; Cernuda-Morollón E; Martínez-Camblor P; Pérez-Alvarez AI; Verano L; García-Cabo C; Serrano-Pertierra E; Pascual J
Cephalalgia; 2017 Aug; 37(9):823-827. PubMed ID: 27250233
[TBL] [Abstract][Full Text] [Related]
7. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
8. Interictal amylin levels in chronic migraine patients: A case-control study.
Irimia P; Martínez-Valbuena I; Mínguez-Olaondo A; Domínguez-Vivero C; Sánchez-Arias JA; Martínez-Vila E; Luquin MR; Leira R
Cephalalgia; 2021 Apr; 41(5):604-612. PubMed ID: 33269952
[TBL] [Abstract][Full Text] [Related]
9. Peripheral, Interictal Serum S100B Levels are Not Increased in Chronic Migraine Patients.
Riesco N; Cernuda-Morollón E; Martínez-Camblor P; Pérez-Pereda S; Pascual J
Headache; 2020 Sep; 60(8):1705-1711. PubMed ID: 32804418
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine.
Rahmann A; Wienecke T; Hansen JM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2008 Mar; 28(3):226-36. PubMed ID: 18254893
[TBL] [Abstract][Full Text] [Related]
11. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
Headache; 2015; 55(7):984-91. PubMed ID: 26129705
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.
Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
Respiration; 2015; 90(5):357-68. PubMed ID: 26447811
[TBL] [Abstract][Full Text] [Related]
13. Similarities and differences between chronic migraine and episodic migraine.
Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal.
Lee MJ; Lee SY; Cho S; Kang ES; Chung CS
J Headache Pain; 2018 Jul; 19(1):53. PubMed ID: 30006780
[TBL] [Abstract][Full Text] [Related]
15. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
16. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
17. Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen.
Cowan RP; Gross NB; Sweeney MD; Sagare AP; Montagne A; Arakaki X; Fonteh AN; Zlokovic BV; Pogoda JM; Harrington MG
Headache; 2021 Mar; 61(3):536-545. PubMed ID: 33724462
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.
Pellesi L; Al-Karagholi MA; De Icco R; Coskun H; Elbahi FA; Lopez-Lopez C; Snellman J; Hannibal J; Amin FM; Ashina M
JAMA Netw Open; 2021 Aug; 4(8):e2118543. PubMed ID: 34357396
[TBL] [Abstract][Full Text] [Related]
19. Analysis of leukocytes in medication-overuse headache, chronic migraine, and episodic migraine.
Forcelini CM; Dantas DC; Luz C; Santin R; Stein AT; Barros HM; Barea LM
Headache; 2011 Sep; 51(8):1228-38. PubMed ID: 21649652
[TBL] [Abstract][Full Text] [Related]
20. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
